Healthcare IT & Genomics

Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.

Reports

Imaging IT – Outpatient Settings - World - 2022

This is a brochure for a new market report on Imaging IT for Outpatient Settings – World – 2022, published in September 2022.

Find out more

Real-World Data - A Strategic Analysis

This is a new study from Signify Research that will examine how the use of this clinically-derived data will emerge and evolve in the near future.

Find out more

Imaging IT – Core Report - World - 2022

This is Signify Research’s 2022 report on the Imaging IT market, published in May 2022.

Find out more

Imaging IT Market Intelligence Service - World - 2022/2023

This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunity for Imaging IT.

Find out more

Laboratory Information Systems – World – 2022 - World - 2022

This is Signify Research’s new report on the world Laboratory Information Systems Market published in May 2022.

Find out more

Structured Reporting Adoption in Imaging IT - World - 2021

This is Signify Research’s 2021 report on the global Structured Reporting Adoption in Imaging IT market.

Find out more

Analyst Insights

Signify Premium Insight: Enlitic Adopts Standard Approach in GE Partnership

Signify Premium Insights Subscription Required

15th September 2022 – GE HealthCare has partnered with medical imaging AI vendor, Enlitic. While most AI vendors are focusing on image analysis, GE has chosen Enlitic for a different reason.

Will 2023 be the Year of Digital Pathology for US Labs?

09th September 2022 – Will 2023 be the Year of Digital Pathology for US Labs? Here is our take on what the recent announcement of 13 new digital pathology add-on codes means for the digital pathology market.

Signify Premium Insight: Screening Marks the Next Step in Intelerad’s Grand Ambition

Signify Premium Insights Subscription Required

2nd September 2022 – Intelerad has continued its acquisition streak with the purchase of PenRad Technologies, a breast and lung screening specialist. The move will differentiate the IT vendor from many of its peers, but, will it help Intelerad seal more deals.

Signify Premium Insight: Making Plans for Pathology

Signify Premium Insights Subscription Required

18th August 2022 – Providers are increasingly stipulating that their Imaging IT vendors are able to facilitate digital pathology capability. This presents an opportunity for these vendors, which are taking different approaches to capitalise on this opportunity.

Signify Premium Insight: The Power of Perspective: AI Vendor Sentiment Index Q2

Signify Premium Insights Subscription Required

11th August 2022 – Signify Research’s Vendor Sentiment Index tracks the confidence levels of key vendors in the AI market. While full details are available in the report, this Premium Insight offers commentary on the key themes.